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Received June 23, 2015; accepted October 18, 2015AbstractBackground: Sleep apnea (SA) was associated with increased prevalence of aortic dissection (AD) in studies that were criticized for either their
small sample size or lack of prospective observation. Using a considerably larger nationwide, population-based database and a long-term
prospective cohort design, our study strived to explore the relationship between SA and the subsequent development of AD.
Methods: From 2000 to 2007, we gathered a study cohort consisting of 15,848 newly diagnosed cases of SA from Taiwan’s National Health
Insurance Research Database. For the control group, another 39,826 individuals without SAwere matched for age, sex, and comorbidity. The two
cohorts were followed-up to observe the occurrence of AD.
Results: During an average 3.59 ± 2.41 years of follow-up, we observed 33 cases of new AD occurrence [non-SA (22, 0.1%) vs. SA (11, 0.1%),
p¼ 0.669], and the incidence of AD was similar for both groups. After adjusting for age, sex, and comorbidity, only age [hazard ratio (HR) 1.03;
95% confidence interval (CI), 1.01e1.06; p¼ 0.006], male gender (HR 2.49; 95% CI, 1.07e5.79; p¼ 0.034), and hypertension (HR 6.28; 95%
CI, 2.36e16.67; p< 0.001) were independently associated with AD diagnosis.
Conclusion: SA was not associated with an increased risk of AD using a large nationwide cohort database. Nonetheless, larger prospective
studies or meta-analyses are recommended to confirm our findings.
Copyright © 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Sleep apnea (SA) is a common disorder characterized by
cessation of breath during sleep, resulting from repetitive
upper airway collapse [namely, obstructive SA (OSA)].1 OSA
affects ~24% of men and ~9% of women in the middle-aged
population of the US2 and is associated with a variety ofsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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disease, stroke, and aortic aneurysm.3e6 Aortic dissection
(AD), a catastrophic illness often presenting as acute hemo-
dynamic compromise, shares some common risk factors with
SA. Based on their study showing a high prevalence (13/19,
68%) of SA in patients with AD, Sampol and colleagues7
recently reported SA as a possible risk factor for AD, in
addition to the well-known risk factors of hypertension, male
sex, and increasing age. Also, a growing body of evidence
supports a tendency toward increased aortic size and aortic
dissection events among patients with SA.7e10 Although taken
as indicating a possible link between OSA and AD, these
studies have also been criticized for their limited sample size
and lack of information from a prospective cohort.
Hypothesizing that SA may contribute independently to the
development of AD, we used a nationwide database to conduct
a nonrandomized, pair-matched cohort study to investigate the
relationship between SA and subsequent development of AD.
2. Methods2.1. DatabaseTaiwan's National Health Insurance (NHI) program, in
operation since 1995, has enrolled nearly all the inhabitants of
Taiwan (21,869,478 beneficiaries out of 22,520,776 in-
habitants at the end of 2002).11 The National Health Insurance
Research Database (NHIRD) at the National Health Research
Institutes (NHRI; http://w3.nhri.org.tw/nhird/en/index.htm) in
Miaoli, Taiwan is in charge of the entire NHI claims database
and publishes numerous extracted datasets for researchers. The
NHRI released a cohort dataset comprised of 1,000,000
randomly sampled people who had been insured from the start
of NHI to 2000, collecting all records of these individuals
from 1995 onwards. The database has been confirmed by
NHRI to be representative of Taiwan's population.12 It is also
one of the largest nationwide population-based databases in
the world, with > 280 published scientific articles using its
data.13 In this cohort dataset, each patient's original identifi-
cation number has been encrypted to protect privacy. The
encrypting procedure is consistent so claims belonging to the
same patient can be linked within the NHIRD datasets.2. 2. Study sample and controlsFig. 1. Flowchart illustrating the follow-up of sleep apnea patients and
matched controls.We identified patients who were newly diagnosed with SA
[International Classification of Diseases, 9th Revision, Clinical
Modification (ICD-9-CM) codes 780.51, 780.53, and 780.57]
from a 1,000,000 sampled cohort dataset going back to
January 1, 2000. An age-, sex-, and comorbidity-matched
control group was selected from the patients without SA
throughout the study period. Patients diagnosed with AD
(ICD-9-CM code 441.0) before enrollment were excluded
from this study.
Comorbidity matched in the two groups included pre-
existing (upon enrollment) hypertension (ICD-9-CM codes
401.xxe405.xx), diabetes mellitus (ICD-9-CM code 250.xx),chronic obstructive pulmonary disease (ICD-9-CM codes 491,
494, 492, and 496), coronary artery disease (ICD-9-CM codes
411.xx, 413.xx, and 414.xx), ischemic stroke (ICD-9-CM
codes 433.xx, 434.xx, 436, and 437.1), intracerebral hemor-
rhage [ICD-9-CM codes 430.xxe432.9x], chronic renal dis-
ease [ICD-9-CM codes 580.xxe587.xx], and peripheral
arterial occlusive disease [ICD-9-CM code 443.9]. Both the
SA cohort and the control cohort were followed-up from
enrollment to the date of AD diagnosis, death, withdrawal
from insurance, or until December 3, 2007; the end of the
follow-up period (Fig. 1).2.3. Main outcomeThe end point of the study was defined as diagnosis with
AD (ICD-9-CM code 441.0). In this database, the ICD codes
for SA and AD did not change throughout the follow-up
period (2001e2007), assuring the consistency of the disease
registry.2.4. Statistical analysisA Microsoft SQL Server 2005 (Microsoft Corporation,
Redmond, WA, USA) was used for data management and
computing. Statistical analyses were performed with SPSS
version 18.0 (SPSS Inc., Chicago, IL, USA). All data are
expressed as mean ± standard deviation or percentage. Com-
parisons between the two groups were determined by inde-
pendent Student t test for continuous variables, or Pearson's c2
test, Yates' correction for continuity/Fisher's exact test for
categorical variables. We used Cox proportional hazard
models to test the association between SA and AD. Survival
analysis was assessed using the KaplaneMeier method, with
significance based on the log-rank test. Statistical significance
was inferred as a two-sided p value < 0.05.
Fig. 2. KaplaneMeier estimates of survival free aortic dissection events in
patients categorized with sleep apnea. The event-free survival rates were
insignificant in the two groups ( p¼ 0.654).
Table 2
Baseline characteristics of the study population.
Aortic dissection p
No (n¼ 55,641) Yes (n¼ 33)
Age (y) 44.77± 17.43 58.48± 13.19 < 0.001
Male 35,468 (63.7) 26 (78.8) 0.106
Hypertension 16456 (29.6) 24 (72.7) < 0.001
Diabetes 6285 (11.3) 4 (12.1) 1.000
COPD 11,948 (21.5) 11 (33.3) 0.148
Coronary artery disease 8041 (14.5) 9 (27.3) 0.065
Ischemic stroke 2230 (4.0) 3 (9.1) 0.296
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A total of 15,848 newly diagnosed SA patients (mean age,
44.92± 17.34 years) were identified from the 1,000,000
sampled cohort dataset between January 2000 and December
2007. Another 39,826 patients without SA (mean age,
44.73± 17.46 years) were matched for age, sex, and comor-
bidity to serve as the control group. The demographic pa-
rameters of the study participants are listed in Table 1.
During an average follow-up period of 3.59± 2.41 years,
there was no significant difference in the incidence of AD
among SA patients compared with the control group [11 (6.9
per 100,000 personeyears) vs. 22 (5.5 per 100,000 persone-
years), p¼ 0.669]. Figure 2 outlines the results of a
KaplaneMeier analysis and the log-rank test, which showed
that patients with SA had no significant difference in AD inci-
dence compared to patients without SA ( p¼ 0.654). Compar-
ison between patients with and without AD is shown in Table 2.
Patients with AD were older, more likely to be male, and more
likely to have hypertension, diabetes mellitus, coronary artery
disease, or ischemic stroke. A Cox proportional hazard
regression model was used to determine the factors indepen-
dently associated with the development of AD. After adjusting
for age, sex, and the above comorbidity, only age [hazard ratio
(HR) 1.03; 95% confidence interval (CI), 1.01e1.06;
p¼ 0.006], male sex (HR 2.49; 95%CI, 1.07e5.79; p¼ 0.034),
and hypertension (HR 6.28; 95% CI, 2.36e16.67; p< 0.001)
were independently associated with AD development. After
adjusting for age, sex, and comorbidity, SAwas not associated
with occurrence of AD (Table 3). Analysis was performed to
demonstrate the role of SA as a factor determining the risk of
AD in subgroups, and SA remained insignificant (Fig. 3).Table 1
Baseline characteristics of the study population.
Sleep apnea p
No (n¼ 39,826) Yes (n¼ 15,848)
Age (y) 44.73± 17.46 44.92± 17.34 0.267
Male 25,407 (63.8) 10,087 (63.6) 0.753
Hypertension 11,820 (29.7) 4,660 (29.4) 0.528
Diabetes 4,536 (11.4) 1,753 (11.1) 0.276
COPD 8,587 (21.6) 3,372 (21.3) 0.468
Coronary artery disease 5,787 (14.5) 2,263 (14.3) 0.455
Ischemic stroke 1,589 (4.0) 644 (4.1) 0.707
Intracerebral hemorrhage 381 (1.0) 176 (1.1) 0.110
Chronic renal disease 1,820 (4.6) 722 (4.6) 0.961
PAOD 893 (2.2) 363 (2.3) 0.753
Antihypertensive medication
ACEI 3,146 (7.9) 1,381 (8.7) 0.002
ARB 2,924 (7.3) 1,611 (10.2) 0.261
a Blocker 6551 (16.4) 3545 (22.4) < 0.0001
b Blocker 6390 (16.0) 3415 (21.5) < 0.0001
CCB 6882 (17.3) 3207 (20.2) < 0.0001
Aortic dissection 22 (0.1) 11 (0.1) 0.669
Data are presented as n (%) or mean± standard deviation. Student t test and c2
tests were used for continuous variables and categorical variables, respectively.
ACEI¼ angiotensin-converting enzyme inhibitor; ARB¼ angiotensin recep-
tor blocker; CCB¼ calcium channel blocker; COPD¼ chronic obstructive
pulmonary disease; PAOD¼ Peripheral arterial obstructive disease.
Intracerebral hemorrhage 556 (1.0) 1 (3.0) 0.766
Chronic renal disease 2541 (4.6) 1 (3.0) 0.996
PAOD 1255 (2.3) 1 (3.0) 1.000
Antihypertensive medication
ACEI 4524 (8.1) 3 (9.1) 1.000
ARB 4532 (8.1) 3 (9.1) 1.000
a Blocker 9796 (17.6) 9 (27.3) 0.219
b Blocker 10,087 (18.1) 9 (27.3) 0.256
CCB 10,075 (18.1) 14 (42.4) 0.001
Sleep apnea 15,837 (28.5) 11 (33.3) 0.669
Data are presented as n (%) or mean± standard deviation. Student t test and c2
tests were used for continuous variables and categorical variables, respectively.
ACEI¼ angiotensin-converting enzyme inhibitor; ARB¼ angiotensin recep-
tor blocker; CCB¼ calcium channel blocker; COPD¼ chronic obstructive
pulmonary disease; PAOD¼ Peripheral arterial obstructive disease.4. Discussion
Using a large nationwide database, we found that SA was
not associated with future risk of AD. Furthermore, our study
confirmed increasing age, hypertension, and male gender as
independent predictors for AD events, consistent with the re-
sults of previous studies.14e16 In particular, the risk of AD
associated with hypertension and being male was upwards of
6.28 (95% CI, 2.36e16.67; p¼ 0.002) and 2.49 (95% CI,
1.07e5.79; p¼ 0.039), respectively. All these results
strengthened the reliability of our findings.
Fig. 3. Hazard ratios, with 95% confidence intervals, for aortic dissection events, according to prespecified sleep apnea subgroups. CAD ¼ coronary artery disease;
COPD¼ chronic obstructive pulmonary disease; DM ¼ diabetes mellitus; HTN ¼ hypertension.
Table 3
Independent predictors of AD identified by Cox regression analysis.
AD occurrence Hazard ratio (95% CI) p
Age (y) 1.03 (1.01e1.06) 0.010
Male 2.49 (1.07e5.79) 0.039
Hypertension 6.28 (2.36e16.67) 0.002
COPD 1.06 (0.49e2.31) 0.911
Coronary artery disease 0.86 (0.36e2.06) 0.391
Antihypertensive medication
CCB 1.20 (0.53e2.70) 0.884
Sleep apnea 1.28 (0.62e2.65) 0.644
AD¼ aortic dissection; CCB¼ calcium channel blocker; CI¼ confidence
interval; COPD¼ chronic obstructive pulmonary disease.
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clinical observations. Cistulli et al14 reported two cases of
Marfan syndrome in which treatment of SA by continuous
positive airway pressure was associated with marked attenu-
ation in aortic dilatation. Furthermore, Sampol et al7 found
that 19 patients with thoracic AD also had a high prevalence
(13/19, 68%) of previously undiagnosed and frequently severe
OSA, suggesting that SAwas associated with the development
of AD. Although detailed mechanisms for such an association
remain undetermined, several possibilities, such as induced
oxygen free-radical production,16,17 activated inflammatory
pathways impairing endothelial function of vessels,18e20
increased sympathetic activity, and precipitating surges in
blood pressure21 have been associated with cardiovascular
system damage, and are suspected of contributing to the
development of AD. However, most of these studies were
based on patients with Marfan syndrome or small, cross-
sectional observations, and have been criticized for theirlack of prospective design. Our study is the first to use a
nationwide insurance cohort database to investigate whether
SA is independently associated with higher risk of developing
AD. Our results show that the incidence of AD was similar
between the SA group and the age-, gender-, and comorbidity-
matched controls. Only increasing age, hypertension, and male
gender, but not SA, were significantly associated with
increased risk of developing AD.
Our findings correlate with the results of previous studies.
Baguet et al10 showed that greater aortic root size was asso-
ciated with severity of OSA in univariate analysis, but after
using a multivariate stepwise regression model to analyzeaortic root size among patients with SA syndrome, diastolic
blood pressure (BP) was the only significant factor for aortic
root size ( p¼ 0.0003). Kohler et al15 reported that an asso-
ciation between SA and AD was no longer significant when
other covariates were forced into multivariate analysis of pa-
tients with Marfan syndrome, suggesting SA is not an inde-
pendent factor, but that multiple associated covariates may
combine to contribute to AD.
Using a nationwide cohort design, our study confirmed that
increasing age, hypertension, and male gender are important
risk factors for developing AD, as previously reported.14e16
Patients with acute D were mostly men aged 60e80
years.22e24 Larson et al22 reported on 161 necropsy patients
with AD, and found that their mean age was 40e63 years, AD
was more common in men, and 52% of these patients had a
history of hypertension. Spittell et al23 reported on 236 pa-
tients with AD, observing that hypertension was the most
common predisposing factor (78% of patients overall). In a
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Acute Aortic Dissection (IRAD), the mean age was 63 years
and 65% were men. In the IRAD registry data, 72% had a
history of hypertension.24 Taken together, our study results
combined with other observations demonstrate that the most
important predisposing factor for acute AD is systemic
hypertension.22e24
Increased aorta size is known to be related to aging, male
gender, hypertension, atherosclerosis and Marfan syndrome,25
and several studies have shown compatible results. Dapunt
et al9 reported that a history of hypertension correlated with a
greater aortic diameter upon diagnosis. Increased thoracic
aorta size is possibly caused by hypertension, but not by SA.
Baguet et al10 concluded that in patients with OSA, nocturnal
hypoxemia decreased baroreflex sensitivity and increased
diastolic BP, the main factor influencing aortic root size.
Although univariate analysis revealed greater aortic root size
was associated with more severe OSA, after using a multi-
variate stepwise regression model, diastolic BP was the only
significant factor for aortic root size ( p¼ 0.0003),10 indicating
that higher BP is still the strongest risk factor for AD. Even so,
it is well established that SA is associated with multiple co-
morbidity. Further larger prospective studies or meta-analyses
are recommended to investigate a possible causal role of SA in
determining AD.
The main strength of our study was its nationwide
population-based database, which can be used to trace nearly
all cases of SA and AD in Taiwan over the study period,
because all cardiologists' and sleep specialists' practices are
covered in our insurance system. Additionally, the large
sample size and cohort study design with controls affords
considerable statistical power for detecting real differences
between the two cohorts, even subtle ones.
There were some limitations of this study worth noting.
Importantly, diagnoses of SA andAD that rely on administrative
claims data registered by physicians or hospitals may be less
accurate than diagnoses made according to standardized
criteria. However, AD is always a serious condition and is
usually diagnosed at a hospital with imaging studies, so these
diagnoses should be correct. In addition, because AD was
identified through ICD codes in an insurance claims database, it
is possible that the incidence of AD may have been under-
estimated. However, the incidence of AD (6.9 per 100,000
personeyears in the SA group, and 5.5 per 100,000 persone-
years in the non-SA group) found in our study is consistent with
previously reported cases,26 indicating our identification of AD
was reliable. Additionally, some personal information was not
available in the administrative data used, including crack
cocaine use and high-intensity weight lifting or other strenuous
resistance training, preventing accurate assessment of the
contributory and confounding effect of these factors. Crack
cocaine accounted for 37% of dissections in a report of a largely
AfricaneAmerican, inner city population.27 High-intensity
weight lifting or other strenuous resistance training may also
cause acute ascending AD, possibly mediated by transient
marked elevation in BP.28 Obesity is also an association factor
for SA. However, body mass index was not available in ourdatabase because of the lack of body weight and height data.
Therefore, the evaluation of obesity was not possible in our
study. Therewere no significant differences between underlying
diseases, including coronary artery disease, stroke, chronic
obstructive pulmonary disease, hypertension, and diabetes
mellitus, but significant differences between drug therapy,
including angiotensin-converting enzyme inhibitors, b
blockers, and calcium channel blockers. Moreover, the SA
group might be associated with more cardiovascular system
damage and high severity and therefore needs more types of
medication. However, we calculated the incidence ofAD in both
groups.No significantly higher incidence ofADwas noted in the
SA group compared to the control group (6.9 per 100,000 per-
soneyears vs. 5.5 per 100,000 personeyears, p¼ 0.669).
Finally, we did not further divide SA into OSA or central type
SA, as the 2001 version of the ICD-9 coding system adopted by
our insurance system has not done so either. Nonetheless,>90%
of patients with SA presenting for polysomnography have
OSA.8 OSA has also been the focus of reports about cardio-
vascular events associated with SA. Whether OSA or central
type SA differ in their contribution to AD deserves further
exploration. The severity of OSA, which was categorized by
ApnoeaeHypopnoea Index, may contribute to AD in different
degrees. However, the Index was not available in our NHIRD
because of the lack of polysomnography results. Therefore, the
severity of OSAwas difficult to evaluate in our study.
In conclusion, we have shown that SA is not associated
with a greater risk of AD, using a large nationwide database.
Furthermore, our study confirmed that increasing age, hyper-
tension, and male gender are independent predictors for AD,
consistent with the results of previous studies. Larger pro-
spective studies or meta-analyses are recommended to confirm
our findings.
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